Instructions to Authors

The Annals of Multidisciplinary Research Insights (AMRI), published by Et Al Publication, welcomes original scholarly work across the sciences, engineering, technology, health, and allied disciplines. Please read these instructions carefully before submitting your manuscript.

The Editorial Process

A manuscript is reviewed for possible publication on the understanding that it is being submitted to AMRI alone at that point in time and has not been published, simultaneously submitted, or already accepted for publication elsewhere. Authors should authorize one of them to correspond with the journal on all matters relating to the manuscript. All manuscripts received are duly acknowledged.

On submission, editors first review each manuscript for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or a lack of significant message are rejected before formal peer review. Manuscripts unlikely to be of interest to AMRI's readership may also be rejected at this stage.

Manuscripts found suitable are sent to two or more expert reviewers. On submission, contributors are invited (but not required) to suggest two or three qualified reviewers with relevant experience; suggested reviewers should not be affiliated with the same institution as the author(s). The final choice of reviewers rests solely with the editor. The journal follows a double-blind review process, in which reviewers and authors remain unaware of each other's identity. Every manuscript is also assigned to a member of the editorial team, who takes the final decision based on the reviewers' comments. Comments and recommendations (acceptance, rejection, or amendment) are conveyed to the corresponding author, who may be asked to provide a point-by-point response and a revised version. This process is repeated until the reviewers and editors are satisfied.

Manuscripts accepted for publication are copy-edited for grammar, punctuation, style, and format. Page proofs are sent to the corresponding author, who is expected to return corrected proofs within three working days; corrections received after this period may not be incorporated. The whole process, from submission to final decision and proofs, is completed online. To achieve faster and wider dissemination, the journal publishes articles online as 'Ahead of Print' immediately on acceptance.

Plagiarism Policy

AMRI is committed to the highest standards of publication ethics and academic integrity.

All submitted manuscripts undergo plagiarism screening before peer review using detection software such as Turnitin and iThenticate. The journal follows COPE guidelines on plagiarism, duplicate publication, and unethical research practices.

Manuscripts exhibiting more than 15% overall similarity, uncited copied content, data fabrication, image manipulation, or duplicate publication are subject to immediate rejection.

Plagiarism checks are performed at initial submission, after major and minor revisions, and before final publication.

Artificial Intelligence Writing Policy

Authors who use generative AI and AI-assisted technologies in writing a manuscript, producing images or graphical elements, or collecting and analyzing data must be transparent and disclose which AI tool was used and how. Authors are fully responsible for the entire content of their manuscript, including any part produced with an AI tool, and are therefore liable for any breach of publication ethics. The specific AI tool used and its purpose should be described in the Methods or Acknowledgments section.

Clinical Trial Registry

Where a submission reports a clinical trial, AMRI supports prospective trial registration and will publish trials registered in a public registry that allows free online access. Acceptable registries include the Clinical Trials Registry – India (ctri.nic.in), ClinicalTrials.gov, the ISRCTN registry (isrctn.org), and the UMIN Clinical Trials Registry (umin.ac.jp/ctr). This applies to trials that began enrollment in or after June 2008. Trials that began enrollment before June 2008 will be considered only if registered retrospectively in a registry offering free public access.

Authorship Criteria

Authorship credit should be based on substantial contributions to:

• the conception and design of the study, the acquisition of data, or the analysis and interpretation of data;

• drafting the article or revising it critically for important intellectual content; and

• final approval of the version to be published.

Simply acquiring funding or collecting data does not justify authorship, nor does general supervision of the research group. Each contributor should be sufficiently involved to take public responsibility for appropriate portions of the content. The order of authors should reflect their relative contribution and, once submitted, cannot be changed without written consent from all contributors. The journal sets a maximum number of authors per manuscript based on its type and scope; where this is exceeded, a justification must be provided.

Contribution Details

Each contributor should describe their specific contributions—for example concept, design, intellectual content, literature search, experimental or field studies, data acquisition, data analysis, statistical analysis, manuscript preparation, editing, and review. One or more authors should take responsibility for the integrity of the work from inception to publication and be designated the guarantor.

Conflicts of Interest / Competing Interests

All authors must disclose any conflicts of interest relating to the manuscript, or to any institutions or products mentioned in it, especially those critical to the study's outcome. Authors must also disclose conflicts of interest with products that compete with those mentioned.

Manuscript Submission

All manuscripts must be submitted online through manuscriptflow.net/journal/amri. First-time users must register (registration is free but mandatory). Registered authors can track their articles after logging in.

If you experience any problems, please contact the editorial office at info@etalpub.com.

Manuscripts not prepared as per these instructions will be returned for technical correction before editorial or peer review. Generally, a manuscript should be submitted as two separate files.

[1] Title Page / First Page File / Covering Letter

This file should include:

• Type of manuscript (e.g. original article, review, case report, systematic review, letter to the editor), title, running title, and the names of all authors/contributors with their highest academic degrees, designations, affiliations, and departments/institutions. All identifying information belongs here. Use text or DOC files and do not zip them.

• Total number of pages and figures, and word counts for the abstract and main text (excluding references, tables, and abstract). For original articles, also provide word counts for the introduction and discussion.

• Sources of support such as grants, equipment, or materials, if applicable.

• Acknowledgments, if any: (1) contributions not justifying authorship, (2) technical help, and (3) financial or material support and its nature. These belong on the title page, not in the main file.

• Whether the manuscript was presented at a meeting (organization, location, date), and a statement on any previous reports that might be considered redundant publication, with references.

• Registration number for any clinical trial, with the registry name and URL.

• Disclosure of conflicts of interest for each author.

• The criteria used to determine authorship.

• A statement that the manuscript has been read and approved by all authors, that authorship requirements have been met, and that each author believes it represents honest work.

• Contact details of the corresponding author (name, address, email, phone), if not in the manuscript itself.

[2] Blinded Article File

This file contains the main text—abstract, main text, and references (including tables)—and must not include authors' names, initials, or the institution where the study was conducted, nor any acknowledgments. Page headers may carry the title but not authors' names. Manuscripts not complying with the blinding policy will be returned. Use only .DOC files, up to 10 MB; if larger, submit images and graphs separately. Number pages consecutively from the first page of the blinded file.

[3] Images

Submit high-quality images, each under 20 MB, reduced to about 1600 × 1200 pixels or 5–6 inches to manage file size. Submit images as JPEG files (not zipped). Image legends should be placed at the end of the manuscript file.

[4] Copyright and Licensing

All articles published in AMRI are open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), available at https://creativecommons.org/licenses/by/4.0/. This license permits unrestricted use, sharing, adaptation, distribution, and reproduction in any medium or format, provided appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

Copyright is retained by the author(s). Authors are required to submit a signed Open Access Licence Agreement Form with their manuscript. By signing, the author(s) confirm that:

• The author(s) retain full copyright and ownership of the article.

• The author(s) grant the Publisher a non-exclusive right to publish the article and distribute it permanently under the CC BY 4.0 license.

• The work is original, has not been published elsewhere, and all co-authors have approved submission.

Authors may deposit the final published version (version of record) in an institutional or subject repository, on a personal or departmental website, or on a preprint server, immediately on publication and with no embargo, provided a link to the published article is included and the journal and Publisher are credited as the original source with a correct citation.

Types of Manuscripts

1. Original Articles

These include randomized controlled trials, intervention and experimental studies, screening and diagnostic studies, outcome studies, cost-effectiveness analyses, case-control series, field studies, and surveys with a high response rate. The text should be 2,000–4,000 words (excluding abstract, references, and tables) and organized into: Abstract, Keywords, Introduction, Materials and Methods (or Methodology), Results, Discussion, References, Tables, and Figure Legends. Include 15–45 references and no more than six authors.

Abstract: a structured abstract of 250 words summarizing the article accurately.

Background: state the purpose and summarize the rationale for the study.

Materials and Methods: describe the methods, apparatus (with manufacturer name and location in parentheses), and procedures in enough detail for others to reproduce the results. Give references for established methods, including statistical methods; describe new or substantially modified methods and evaluate their limitations. Identify all materials, drugs, and chemicals precisely.

Ethics (where applicable): When reporting studies involving human participants, indicate whether the procedures followed the ethical standards of the responsible committee and the Declaration of Helsinki. For prospective studies involving human participants, state approval by the relevant institutional or independent ethics committee, and confirm that informed consent (and assent, where required) was obtained. Ensure participant confidentiality. When reporting experiments on animals, indicate whether institutional or national guidelines on the care and use of laboratory animals were followed, and detail anesthetics and analgesics used. Evidence of ethics approval must be supplied on demand. Manuscripts that are ethically unacceptable will not be considered. A statement on ethics approval must be included under Materials and Methods for all applicable research.

Reporting guidelines: Authors should follow the recognized reporting guideline for their study design (see table below). Reports of randomized controlled trials should follow the CONSORT statement.

Statistics: Quantify findings and present them with appropriate indicators of uncertainty (e.g. confidence intervals). Report losses to observation. Define statistical terms, abbreviations, and symbols, and specify the software used. Provide exact P values. Mean differences, proportions, and relative risks (including odds and hazard ratios) should be accompanied by confidence intervals.

Results: Present results in a logical sequence in text, tables, and illustrations, giving the most important findings first. Do not repeat all tabulated data in the text; give both absolute numbers and derivatives such as percentages. Restrict tables and figures to those needed to support the argument.

Discussion: Summarize key findings; state strengths and limitations; interpret results in the context of the totality of evidence; note what the study adds, its implications, controversies, and future research directions. Do not repeat data from the Introduction or Results.

2. Review Articles

Reviews should be written by contributors who have done substantial work on, or are experts in, the subject. A short summary of the contributor's work in the field should accompany the manuscript.

• Word count: 2,500–6,000 words (excluding tables, references, and abstract)

• References: 20–90

• Abstract: unstructured, 250 words

• Authors: up to 6

Section titles depend on the topic. Authors should describe the methods used to locate, select, extract, and synthesize data, summarized in the abstract. Brief post-publication updates may be submitted as Letters to the Editor when major developments occur.

3. Case Reports / Case Series

New, interesting, and rare cases that present a significant diagnostic or therapeutic challenge and a clear learning point may be reported. Submissions should follow the CARE reporting guidelines.

• Word count: 1,000–2,500 words (excluding abstract and references)

• References: 10–25

• Authors: up to 6

• Abstract: structured, 250 words (Background, Case Presentation, Conclusion)

• Sections (in order): Abstract, Keywords, Introduction, Case Report, Discussion, References, Tables, and Legends

Patient confidentiality must be maintained. Identifying information must not appear in the manuscript or images, and written informed consent for publication must be obtained and provided on request.

4. Systematic Reviews

Systematic reviews provide a comprehensive, transparent, and reproducible synthesis of evidence on a clearly defined question. They should follow PRISMA and, where applicable, be registered in PROSPERO or an equivalent registry, with the registration number disclosed.

• Word count: 2,500–6,500 words (excluding tables, references, and abstract)

• References: 20–90

• Abstract: structured, 250 words (Background, Methods, Results, Conclusion)

• Authors: up to 6

• Sections: Abstract, Keywords, Introduction, Methods (search strategy, eligibility criteria, data extraction, risk-of-bias assessment, synthesis methods), Results (including the PRISMA flow diagram), Discussion, Conclusion, References, Tables, and Figure Legends

Meta-analyses, where appropriate, should include forest plots and an assessment of heterogeneity and publication bias.

5. Letter to the Editor

Short, decisive observations, preferably relating to articles previously published in the journal. They should not be preliminary observations requiring a later paper for validation. Up to 1,000 words and 10 references, generally by no more than four authors.

Special Issues are not entertained by the journal at this time.

Summary Table of Manuscript Specifications

Note on limits: Manuscripts exceeding the prescribed word, reference, or author limits may be considered case by case. Authors must submit a formal request with justification at the time of submission; the final decision rests with the Editorial Board.

Reporting Guidelines